DexCom, Inc.
DXCM Healthcare Medical Devices
DexCom, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.7 billion, up 15.6% from fiscal 2024. In the quarter to June 2026, revenue grew 13.1%, EPS grew 41.3%, free cash flow fell 11.7% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for ten consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
Follow DXCM
DexCom, Inc. (DXCM) Return on invested capital
DexCom, Inc.'s return on invested capital over the twelve months to 30 June 2026 was 37.1%, up 8.5 percentage points from fiscal 2025 (28.7%). Over the past ten years it has ranged from −40.4% (fiscal 2018) to 49.3% (fiscal 2024); the current reading is higher than 91% of that period. That is above the Medical Devices industry median of −10.3% and above the Healthcare sector median of 0.00%.
Return on invested capital, annual
Embed this chart
Annual newest first
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2025 | 28.7% | (20.67) |
| FY2024 | 49.3% | 28.33 |
| FY2023 | 21.0% | 6.14 |
| FY2022 | 14.9% | 2.21 |
| FY2021 | 12.7% | (10.66) |
| FY2020 | 23.3% | 2.28 |
| FY2019 | 21.0% | 61.46 |
| FY2018 | −40.4% | (27.04) |
| FY2017 | −13.4% | 10.65 |
| FY2016 | −24.0% | 8.91 |
Against its own ten years
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| DXCM DexCom, Inc. | 37.1% |
| PEN Penumbra, Inc. compare | 13.1% |
| EW Edwards Lifesciences Corporation compare | 12.8% |
| GEHC GE HealthCare Technologies Inc. compare | 8.37% |
| STE STERIS plc compare | 8.27% |
| BSX Boston Scientific Corporation compare | 6.96% |
| PHG Koninklijke Philips N.V. compare | 6.69% |
| ZBH Zimmer Biomet Holdings, Inc. compare | 3.82% |
| SNN Smith & Nephew SNATS, Inc. compare | 0.00% |
| Medical Devices industry median | −10.3% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)
More on DXCM
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement